'AI is only as smart as the data and the people behind it', says Kyle Ryan

Unveiling AI's Potential: Kyle Ryan Insights on Data and Ingenuity
Kyle Ryan believes that innovative concepts, data-driven insights, precise engineering, and efficient execution combine to create great products. He also believes that leadership is essential for innovation. Read on to know his thoughts on the role of leadership and technology in healthcare industry.

A leader is there to serve others, and I put it into distinct practice.

Media 7: How have your leadership style and people management skills evolved over the course of your inspiring career trajectory?
Kyle Ryan:
As I’ve grown my career over the past two decades, what has become most apparent to me and most important to my leadership style is how much people matter. When I started at Sony, I grew a lot as a leader going from a front line worker and young engineer to a relatively high leadership position as the VP of Technology. That role really honed in on the importance of being people-oriented. I'm a very big advocate of servant leadership, meaning a leader is there to serve others, and I put it into distinct practice as I oversaw a team of more than 750 individuals with very diverse backgrounds and in various types of roles. I strive to instill a culture of servant leadership amongst my leadership team and all levels of management to enable them to worry less about their own success and more about the success of the people they serve. My people management skills have definitely continued to mature and evolve throughout my career. And all of that has led me to this role. It’s led me to be able to apply some of those things that I learned from others, as naturally, you learn from all those that you work with, and work for, over the course of your career. It's very rewarding to see people improve, to help them through challenges, and to help them grow their careers and see their own progression.

M7: What are some of the biggest trends and challenges that CTOs from the world of medicine face today?
KR:
One of the biggest challenges is around the interoperability of healthcare data. There is currently a significant focus on interoperability in the US. But the reality is, it's going to take decades to solve, and will really require some true innovation, creative thinking, and collaboration. Now, governments are stepping in to try and encourage this cooperation by setting certain types of rules and regulations. I think, in the end, interoperability will require us all, in the private sector, to embrace data sharing and standardization, and to an extent, self-monitor this exercise so that it can become a reality.

It's very arduous today for patients to have a seamless healthcare experience with the various doctors they see who are using different types of technology systems. Not being able to treat a patient holistically can mean that patient outcomes suffer as disparate systems can be less reliable and more cumbersome for providers.

The other challenge we face is on the clinical side. Doctors today are frustrated, because they're actually less efficient with software than they are with a pen and paper. It's our responsibility, as technologists and owners of the software and software development, to make the software solution as fast and convenient as a pen and a piece of paper. We need to ensure the software has all the other benefits that come from the fact that it is digital, searchable, and reportable, unlike a pen and a piece of paper. Our goal is to allow providers to focus on their patients and not on the computer.

M7: Kindly share your thoughts on how the rise of telemedicine and remote care is impacting the healthcare industry?
KR:
The silver lining to the COVID-19 pandemic was the adoption of virtual visits, and the convenience that it provides. The efficiency that telemedicine provides to both the practice provider and the patient is a really cool win. I believe it's here to stay. Naturally, more of the in-person appointments have come back as pandemic restrictions have lessened. But we still see most practices on a daily basis leverage remote care systems, tele health being one of those. As we introduce more high-competence technology, wearables, and other devices that can provide confidence and trusted data, our challenge is to make sure our software integrates with those, and stays ahead as those trends continue to evolve.

Read more: Q&A with Matthew Sappern, CEO at PeriGen


I think interoperability has also continued to be reinforced by the results of the pandemic and will drive policy and regulatory requirements of the future.

M7: How can healthcare organizations balance the need for financial sustainability with the imperative to provide high-quality care? Please shed light.
KR:
This is a tough one for independent practices. Not only did they not go to school to manage a host of software solutions, they also didn't go to school to be small business owners. So these are all new things for them. They often find themselves struggling to wrap their arms around all the software solutions they need to run their small business, from their EHR to billing and payroll systems.  Being a small business owner wrangling all these decisions and systems makes it particularly challenging to survive as an independent healthcare practice. Of course, the rate at which they can see patients is the heart of their survival. When they look at what's impeding their ability to provide the quality care that they want, they want an efficient way to get rid of roadblocks, while increasing their revenue.

We must improve the clinical and billing healthcare software solutions. They must become more automated, and become more streamlined, so providers can spend their time caring for patients and getting the quality, maximum throughput they expect At Tebra, we truly believe we are a partner, an enabler to them, taking care of running their business while they do what they need to focus on, which is patient care.

M7: What are the latest trends in healthcare management, and what all problems do they aim to solve?
KR: 
AI has always been top of mind for us; this is not a new topic by any means. AI is definitely something we need to leverage, and it’s something we talk about regularly at Tebra. AI is leveraged by most industries and can be a powerful tool to bring automation and innovation to the healthcare space. We need to marry machine learning with AI. That is super critical to making a true difference. AI is only as smart as the data and the people behind it. In any scenario, it can only produce quality content based on the data that it's leveraging in the first place.
There are tons of ideas - we have to leverage these technologies to improve efficiency and drive new value in automation.

The other big advancement that is a consistent theme with the survival of a small business independent practice is around the desire for an all-in-one software platform. When providers are dealing with 15-point solutions that don't talk to each other, it’s very stressful and costly. They end up duplicating data and data entry, and it's very inefficient. So what we've done at Tebra is exactly what the market wants. Providers want one complete operating solution where all of these transition points along the journey of patient care and billing are seamless, and they can see the whole lifecycle. What's really great is, in the end, we're going to be able to show a provider the kinds of metrics that we track as a business, like lifetime value. We will be able to show them what it cost them to acquire that patient and how much value they have gotten from that patient. As a business, it'll be really quite ground breaking.

M7:  How does your organization ensure the privacy and security of patient data?
KR:
We take our clients’ privacy and patient data very seriously at Tebra. You can actually never be too careful. We engage external certified bodies and independent auditors to ensure that the Tebra environment meets or exceeds applicable regulatory requirements and industry best practices. We also regularly give webinars and share thought leadership with our clients to make sure they are current with cybersecurity best practices, such as keeping software updated, using a password manager, and enabling multi-factor authentication.

Read more: Q&A with Fredrik Sundberg, Global Director Strategic Customer Relations at Cytiva


It's very arduous today for patients to have a seamless healthcare experience with the various doctors they see who are using different types of technology systems.

M7: According to you, what are the best practices that modern healthcare entities should adopt to serve patients better?
KR:
 An all-in-one solution is a best practice because it gives providers improved efficiency. After they adopt it, they'll have a lower operating cost of their business and an overall less stressful and simpler life. In turn, patients will have improved quality care since their doctor can be more focused on them and have an overall better experience.
 
M7: Brief us about Tebra’s solutions.
KR:
In 2021, with a combined mission to unlock better healthcare, Kareo and PatientPop joined forces to form Tebra — the operating system for the connected practice of the future. With an all-in-one, purpose-built platform to drive practice success and modernize every step of the patient journey, Tebra provides digital tools and support to attract new patients, deliver modern care, get paid quickly, and operate efficiently. Tebra helps providers meet the needs of the modern healthcare landscape and makes it easier for their patients to access the care they need and have grown to expect from their providers.Kareo, a Tebra company, enables powerful EHR and telehealth solutions, as well as helps providers manage billing and payments and much more. PatientPop, a Tebra company, helps those providers grow their business with leading marketing solutions and communicates with their patients via two-way texting, online scheduling, and a patient portal.

M7: How has the pandemic impacted healthcare policy and regulations?
KR:
One positive thing that came from the COVID-19 pandemic was the fact that there were policy changes. For example, telehealth visits have become reimbursable.Prior to that, they weren't really considered official appointments, and it was very difficult for a provider to receive payment from a telehealth visit. That's all completely changed. It started off as a temporary reimbursement, and then only recently has extended. While it's still not officially permanent, It is anticipated to become a permanent change. I think interoperability has also continued to be reinforced by the results of the pandemic and will drive policy and regulatory requirements of the future.

M7: How has Tebra evolved since its founding, and what are its plans for future growth?
KR:
Tebra now has more than 1,000 employees dedicated to supporting 170k providers who provide care to 113M patients across the country. Since its inception, Tebra has mainly served smaller practices, but the company has been incrementally expanding its service to larger ones of up to 20 doctors. Tebra is also currently expanding the number of medical specialties it supports, an initiative fueled by its new capital injection from Golub Capital in 2021, which earned the company unicorn status.

As it works to develop an end-to-end platform to modernize healthcare practices, Tebra is investing first and foremost in completing the combination of Kareo and PatientPop’s software. The company is also scaling across sales and marketing with the goal of expanding its platform’s network. Additionally, Tebra plans to build out new capabilities for its SaaS platform to extend its business into new areas, including developing card-payment software and entering the fintech space. It also is creating a consumer-facing facet of its platform where patients would be able to easily find local, in-network healthcare providers.  

ABOUT TEBRA

Tebra provides digital tools and assistance for independent healthcare practices to flourish in the new era of healthcare. Tebra is always looking ahead in order to support healthcare providers with solutions for the future. In their mission to facilitate the success of medical practices, the company provides comprehensive solutions for practice operations and growth through their two flagship products, Kareo and PatientPop. To know more please visit: https://www.tebra.com/

More C-Suite on deck

James Bates on Shifting Perspectives: From AI as a Job Threat to AI as a Vital Workforce Aid in Healthcare

Media 7 | October 19, 2023

Step into the transformative world of healthcare with James Bates, an accomplished CEO, entrepreneur, and board member who has driven high-growth plans for leading technology companies. As the Chairman and Founder of AdviNow Medical, James has conceptualized a groundbreaking vision, raised capital, and launched the world's first Artificial Intelligence and Augmented Reality-driven automated medical visit system. Join us for an illuminating conversation with James Bates, a visionary leader in healthcare technology.

Read More

Q&A with Matthew Sappern, CEO at PeriGen

Media 7 | September 30, 2021

Matthew Sappern, CEO at PeriGen, had served as a corporate officer for Eclipsys Corporation before and during its merger with Allscripts. Leading up to the merger, Sappern served as Eclipsys Senior Vice President of Professional Services, responsible for the company’s $100M consulting, implementation and training P&L. Sappern joined Eclipsys in January 2003, as VP of product development in the software engineering division. Over a time of three years, he came to run 75 percent of the development operation and oversaw the delivery of three critical enterprise software releases in record time for the company.

Read More

Q&A with Anna Baecklund, CTO & Founder at Oppioo

Media 7 | September 21, 2021

Anna Baecklund, CTO & Founder at Oppioo, is a Data Scientist Leader, A skilled communicator capable of explaining complex issues with clarity to diverse audiences. With MSc in engineering physics, Anna is responsible for leading innovation using data science including the development of new insights, advanced modelling techniques, and AI capabilities. With Oppio, An AI companion app, she aims to motivate cancer patients who want to speed up and improve their rehab.

Read More

James Bates on Shifting Perspectives: From AI as a Job Threat to AI as a Vital Workforce Aid in Healthcare

Media 7 | October 19, 2023

Step into the transformative world of healthcare with James Bates, an accomplished CEO, entrepreneur, and board member who has driven high-growth plans for leading technology companies. As the Chairman and Founder of AdviNow Medical, James has conceptualized a groundbreaking vision, raised capital, and launched the world's first Artificial Intelligence and Augmented Reality-driven automated medical visit system. Join us for an illuminating conversation with James Bates, a visionary leader in healthcare technology.

Read More

Q&A with Matthew Sappern, CEO at PeriGen

Media 7 | September 30, 2021

Matthew Sappern, CEO at PeriGen, had served as a corporate officer for Eclipsys Corporation before and during its merger with Allscripts. Leading up to the merger, Sappern served as Eclipsys Senior Vice President of Professional Services, responsible for the company’s $100M consulting, implementation and training P&L. Sappern joined Eclipsys in January 2003, as VP of product development in the software engineering division. Over a time of three years, he came to run 75 percent of the development operation and oversaw the delivery of three critical enterprise software releases in record time for the company.

Read More

Q&A with Anna Baecklund, CTO & Founder at Oppioo

Media 7 | September 21, 2021

Anna Baecklund, CTO & Founder at Oppioo, is a Data Scientist Leader, A skilled communicator capable of explaining complex issues with clarity to diverse audiences. With MSc in engineering physics, Anna is responsible for leading innovation using data science including the development of new insights, advanced modelling techniques, and AI capabilities. With Oppio, An AI companion app, she aims to motivate cancer patients who want to speed up and improve their rehab.

Read More

Related News

Healthcare Analytics

SHL Medical partners with SteriPack Group to set up final assembly service

SHL Medical | January 24, 2024

SHL Medical, a world-leading solutions provider of advanced drug delivery systems and SteriPack Group, renowned global supplier of secondary packing and final assembly services to the pharmaceutical industry, enter a non-exclusive strategic partnership. Together, they aim to establish a pre-validated final assembly service at the SteriPack facility in Poland, enhancing the overall flexibility of supply chain strategies for their customers. In addition to SHL Medical's existing final assembly, labeling, and packaging­ services in the United States, this collaboration extends high-quality CMO options to Europe. Markus Puusepp, SHL Medical's Chief Growth Officer, expressed enthusiasm about the partnership, stating "This partnership is a significant addition to the Molly® platform value proposition. We share common values with SteriPack, from focus on the customer to a commitment to quality, making the decision to collaborate straightforward." Recognizing the importance of flexibility and time-to-market, especially in clinical production, the partnership with SteriPack will offer SHL Medical's customers highly flexible and personalized final assembly and packaging solutions. This is particularly beneficial for small batch handling in clinical supply and niche markets like rare diseases. Emphasizing the comprehensive capabilities of the Molly platform, SHL Medical aims to deliver right-sized solutions that ensure improved service, faster timelines, and a more streamlined supply chain for its diverse customer base. John Ward, SteriPack Group's VP Pharmaceutical Solutions commented "SteriPack Group looks forward to supporting SHL Medical and their customers in providing quality and flexible solutions to a fast- moving market. With an emphasis on creating service solutions designed around specific customer requirements, this partnership will make the process of working with the Molly® platform an easy decision." About SHL Medical As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by its company purpose – Enabling Patients' Independence – SHL Medical offers patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. It also offers final assembly, labeling, and packaging solutions for its drug delivery systems. In response to the rising trend in home therapy, SHL Medical has increased its developmental work in the digital healthcare sector to help improve the drug delivery ecosystem. Located across Switzerland, Taiwan, Sweden, and the US, SHL Medical's global team of experts collaborate seamlessly as one team in utilizing its comprehensive in-house manufacturing capabilities. Its solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into its designs and processes to contribute to a cleaner earth. About SteriPack Group SteriPack Group is a globally renowned contract packing and manufacturing organisation serving the pharmaceutical and medical device sectors respectively. With a strong emphasis on innovation, quality and compliance, SteriPack's services to the pharmaceutical industry include device design and development, final assembly, labelling, secondary packing, serialisation and aggregation of injectable formats including vials, pre-filled syringes, and autoinjectors. SteriPack's tailored customer-focused solutions make it an ideally suited supplier for small to medium-sized batch volumes required for a growing market of targeted therapies as well as clinical trials. Its proven capabilities in cleanroom assembly and labelling as well as secondary packing services for drug delivery systems and medical devices, combined with significant investment into growing cold chain storage capacity, have helped to make it a trusted partner to top global pharmaceutical companies.

Read More

Healthcare Analytics

Aya Healthcare Expands into UK with ID Medical Acquisition

Aya Healthcare | January 17, 2024

Aya Healthcare, the largest healthcare talent software and staffing company in the United States, today announced the acquisition of ID Medical, a leading workforce solutions provider in the United Kingdom (U.K.). ID Medical brings over 20 years of experience providing the National Health Service (NHS) and other healthcare organizations with innovative workforce solutions, including workforce management, international recruitment and temporary healthcare staffing. As part of the acquisition, ID Medical will make Aya Healthcare’s market-leading technology available to the NHS and U.K.-based clinicians. The companies plan to share best practices from each market with their respective clients. “We are excited about ID Medical joining the Aya family of brands. We believe that we will deliver enhanced value to our respective clients and clinicians through this cross-Atlantic collaboration,” said Alan Braynin, president and CEO of Aya Healthcare. ID Medical will continue to operate as its own brand in the U.K., supporting thousands of healthcare professionals and hundreds of healthcare organizations. “We are excited to join Aya in our shared mission to transform the healthcare industry worldwide,” said Deenu Patel, CEO of ID Medical. “With Aya’s support, we’ll have access to additional resources, technology and expertise to enhance our services and expand our impact.” About Aya Healthcare Aya Healthcare is the largest healthcare talent software and staffing company in the United States. Aya operates the world’s largest digital staffing platform delivering every component of healthcare-focused labor services, including travel nursing and allied health, per diem, permanent staff hiring, interim leadership, locum tenens and non-clinical professionals. Aya’s software suite, which includes vendor management, float pool technology, provider services and predictive analytics, provides hospital systems greater efficiencies, superior operating results and reduced labor costs. While technology drives efficiency and scale, Aya’s 7,000+ global employees power the company to deliver unparalleled accountability and exceptional experiences for clients and clinicians. Aya’s company culture is rooted in giving back and supports organizations around food security, education, healthcare, safe shelter and equity.

Read More

Digital Healthcare

UCI Health Reaches Definitive Agreement to Acquire Four Southern California Hospitals From Tenet Healthcare Corporation

UCI Health | February 02, 2024

The Regents of the University of California, on behalf of the University of California, Irvine, has entered into a definitive agreement with Tenet Healthcare Corporation to acquire Tenet's Pacific Coast Network. The network will become part of UCI Health, the clinical enterprise of UC Irvine. "UC Irvine has deepened its healthcare commitment to the future of Orange County, our region and California," said UC Irvine Chancellor Howard Gillman. "This journey in healthcare is deeply intertwined with the University of California's dedication to bettering our communities, expanding access to premier healthcare, and pioneering the medical innovations of tomorrow, today. Our vision will bridge gaps in regional care and reinforce UCI's place among the nation's leading academic health systems while advancing solutions to challenges facing healthcare." Pending customary regulatory approvals, clearances, and closing conditions, the proposed acquisition would bring four medical centers in Lakewood, Los Alamitos, Fountain Valley and Placentia and associated outpatient locations into the UCI Health system. UCI Health currently delivers care at UCI Medical Center in Orange and a growing network of multispecialty care centers. "At UCI Health, we are excited to add these new care sites to the UCI Health network and extend the benefits of our compassionate, high-level care, clinical innovation, and scientific discovery," said Chad Lefteris, president and chief executive officer of UCI Health. "As Orange County's only academic health system, UCI Health is unique in its ability to offer the highest level of advanced care powered by the research and innovation of a world-class public research institution." UCI Health recognizes a unique opportunity to build on the quality care already being delivered in the communities served by Tenet Healthcare's Pacific Coast Network. "These four hospitals are well-regarded in their communities for providing high-quality, compassionate care," said Saum Sutaria, M.D., chairman and chief executive officer of Tenet Healthcare. "The local communities will benefit from the nationally recognized advancements, medical knowledge, research, and community focus that UCI Health brings as an innovative academic health system. UCI Health recognizes a unique opportunity to build on the quality care already being delivered in the communities served by the Pacific Coast Network." In a region with a population greater than that of two dozen states, UCI Health operates the only Level I trauma center, locally based National Cancer Institute-designated comprehensive cancer center, high-risk perinatal-neonatal service and is the largest regional burn center and leading provider of complex tertiary and quaternary care. The system's clinical excellence has consistently placed UCI Health in the top 10 for quality and safety among the nation's leading comprehensive academic health systems. The acquisition also means more patients will have access to advanced therapies in the region's largest and most diverse portfolio of clinical trials, ranging from cancer to neurosciences, digestive diseases, orthopedics and internal medicine specialties. UCI Health and Tenet Healthcare's Pacific Coast Network patients can continue receiving care at their local facilities as they normally would from the care teams they know and trust. The transaction is expected to be completed in spring 2024, subject to customary regulatory approvals, clearances, and closing conditions. "It is a privilege to provide world-class care to Californians and we are excited to welcome the clinicians and co-workers from these Tenet Healthcare sites to UCI Health as partners in improving the health of local communities," Lefteris said. About UCI Health UCI Health is the clinical enterprise of the University of California, Irvine, and the only academic health system in Orange County. Patients can access UCI Health at primary and specialty care offices across Orange County and at its main campus, UCI Medical Center in Orange, Calif. The 459-bed, acute care hospital, listed among America's Best Hospitals by U.S. News & World Report for 23 consecutive years, provides tertiary and quaternary care, ambulatory and specialty medical clinics, behavioral health and rehabilitation services. UCI Medical Center is home to Orange County's only National Cancer Institute-designated comprehensive cancer center, high-risk perinatal/neonatal program and American College of Surgeons-verified Level I adult and Level II pediatric trauma center, gold level 1 geriatric emergency department and regional burn center. About UC Irvine About the University of California, Irvine: Founded in 1965, UCI is a member of the prestigious Association of American Universities and is ranked among the nation's top 10 public universities by U.S. News & World Report. The campus has produced five Nobel laureates and is known for its academic achievement, premier research, innovation and anteater mascot. Led by Chancellor Howard Gillman, UCI has more than 37,000 students and offers 224 degree programs. It's located in one of the world's safest and most economically vibrant communities and is Orange County's second-largest employer, contributing $7 billion annually to the local economy and $8 billion statewide. About Tenet Healthcare Tenet Healthcare Corporation is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates or has ownership interests in more than 480 ambulatory surgery centers and surgical hospitals. We also operate 58 acute care and specialty hospitals, approximately 110 other outpatient facilities, a network of leading employed physicians and a global business center in Manila, Philippines. Our Conifer Health Solutions subsidiary provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers, and other clients. Across the Tenet enterprise, we are united by our mission to deliver quality, compassionate care in the communities we serve.

Read More

Healthcare Analytics

SHL Medical partners with SteriPack Group to set up final assembly service

SHL Medical | January 24, 2024

SHL Medical, a world-leading solutions provider of advanced drug delivery systems and SteriPack Group, renowned global supplier of secondary packing and final assembly services to the pharmaceutical industry, enter a non-exclusive strategic partnership. Together, they aim to establish a pre-validated final assembly service at the SteriPack facility in Poland, enhancing the overall flexibility of supply chain strategies for their customers. In addition to SHL Medical's existing final assembly, labeling, and packaging­ services in the United States, this collaboration extends high-quality CMO options to Europe. Markus Puusepp, SHL Medical's Chief Growth Officer, expressed enthusiasm about the partnership, stating "This partnership is a significant addition to the Molly® platform value proposition. We share common values with SteriPack, from focus on the customer to a commitment to quality, making the decision to collaborate straightforward." Recognizing the importance of flexibility and time-to-market, especially in clinical production, the partnership with SteriPack will offer SHL Medical's customers highly flexible and personalized final assembly and packaging solutions. This is particularly beneficial for small batch handling in clinical supply and niche markets like rare diseases. Emphasizing the comprehensive capabilities of the Molly platform, SHL Medical aims to deliver right-sized solutions that ensure improved service, faster timelines, and a more streamlined supply chain for its diverse customer base. John Ward, SteriPack Group's VP Pharmaceutical Solutions commented "SteriPack Group looks forward to supporting SHL Medical and their customers in providing quality and flexible solutions to a fast- moving market. With an emphasis on creating service solutions designed around specific customer requirements, this partnership will make the process of working with the Molly® platform an easy decision." About SHL Medical As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by its company purpose – Enabling Patients' Independence – SHL Medical offers patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. It also offers final assembly, labeling, and packaging solutions for its drug delivery systems. In response to the rising trend in home therapy, SHL Medical has increased its developmental work in the digital healthcare sector to help improve the drug delivery ecosystem. Located across Switzerland, Taiwan, Sweden, and the US, SHL Medical's global team of experts collaborate seamlessly as one team in utilizing its comprehensive in-house manufacturing capabilities. Its solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into its designs and processes to contribute to a cleaner earth. About SteriPack Group SteriPack Group is a globally renowned contract packing and manufacturing organisation serving the pharmaceutical and medical device sectors respectively. With a strong emphasis on innovation, quality and compliance, SteriPack's services to the pharmaceutical industry include device design and development, final assembly, labelling, secondary packing, serialisation and aggregation of injectable formats including vials, pre-filled syringes, and autoinjectors. SteriPack's tailored customer-focused solutions make it an ideally suited supplier for small to medium-sized batch volumes required for a growing market of targeted therapies as well as clinical trials. Its proven capabilities in cleanroom assembly and labelling as well as secondary packing services for drug delivery systems and medical devices, combined with significant investment into growing cold chain storage capacity, have helped to make it a trusted partner to top global pharmaceutical companies.

Read More

Healthcare Analytics

Aya Healthcare Expands into UK with ID Medical Acquisition

Aya Healthcare | January 17, 2024

Aya Healthcare, the largest healthcare talent software and staffing company in the United States, today announced the acquisition of ID Medical, a leading workforce solutions provider in the United Kingdom (U.K.). ID Medical brings over 20 years of experience providing the National Health Service (NHS) and other healthcare organizations with innovative workforce solutions, including workforce management, international recruitment and temporary healthcare staffing. As part of the acquisition, ID Medical will make Aya Healthcare’s market-leading technology available to the NHS and U.K.-based clinicians. The companies plan to share best practices from each market with their respective clients. “We are excited about ID Medical joining the Aya family of brands. We believe that we will deliver enhanced value to our respective clients and clinicians through this cross-Atlantic collaboration,” said Alan Braynin, president and CEO of Aya Healthcare. ID Medical will continue to operate as its own brand in the U.K., supporting thousands of healthcare professionals and hundreds of healthcare organizations. “We are excited to join Aya in our shared mission to transform the healthcare industry worldwide,” said Deenu Patel, CEO of ID Medical. “With Aya’s support, we’ll have access to additional resources, technology and expertise to enhance our services and expand our impact.” About Aya Healthcare Aya Healthcare is the largest healthcare talent software and staffing company in the United States. Aya operates the world’s largest digital staffing platform delivering every component of healthcare-focused labor services, including travel nursing and allied health, per diem, permanent staff hiring, interim leadership, locum tenens and non-clinical professionals. Aya’s software suite, which includes vendor management, float pool technology, provider services and predictive analytics, provides hospital systems greater efficiencies, superior operating results and reduced labor costs. While technology drives efficiency and scale, Aya’s 7,000+ global employees power the company to deliver unparalleled accountability and exceptional experiences for clients and clinicians. Aya’s company culture is rooted in giving back and supports organizations around food security, education, healthcare, safe shelter and equity.

Read More

Digital Healthcare

UCI Health Reaches Definitive Agreement to Acquire Four Southern California Hospitals From Tenet Healthcare Corporation

UCI Health | February 02, 2024

The Regents of the University of California, on behalf of the University of California, Irvine, has entered into a definitive agreement with Tenet Healthcare Corporation to acquire Tenet's Pacific Coast Network. The network will become part of UCI Health, the clinical enterprise of UC Irvine. "UC Irvine has deepened its healthcare commitment to the future of Orange County, our region and California," said UC Irvine Chancellor Howard Gillman. "This journey in healthcare is deeply intertwined with the University of California's dedication to bettering our communities, expanding access to premier healthcare, and pioneering the medical innovations of tomorrow, today. Our vision will bridge gaps in regional care and reinforce UCI's place among the nation's leading academic health systems while advancing solutions to challenges facing healthcare." Pending customary regulatory approvals, clearances, and closing conditions, the proposed acquisition would bring four medical centers in Lakewood, Los Alamitos, Fountain Valley and Placentia and associated outpatient locations into the UCI Health system. UCI Health currently delivers care at UCI Medical Center in Orange and a growing network of multispecialty care centers. "At UCI Health, we are excited to add these new care sites to the UCI Health network and extend the benefits of our compassionate, high-level care, clinical innovation, and scientific discovery," said Chad Lefteris, president and chief executive officer of UCI Health. "As Orange County's only academic health system, UCI Health is unique in its ability to offer the highest level of advanced care powered by the research and innovation of a world-class public research institution." UCI Health recognizes a unique opportunity to build on the quality care already being delivered in the communities served by Tenet Healthcare's Pacific Coast Network. "These four hospitals are well-regarded in their communities for providing high-quality, compassionate care," said Saum Sutaria, M.D., chairman and chief executive officer of Tenet Healthcare. "The local communities will benefit from the nationally recognized advancements, medical knowledge, research, and community focus that UCI Health brings as an innovative academic health system. UCI Health recognizes a unique opportunity to build on the quality care already being delivered in the communities served by the Pacific Coast Network." In a region with a population greater than that of two dozen states, UCI Health operates the only Level I trauma center, locally based National Cancer Institute-designated comprehensive cancer center, high-risk perinatal-neonatal service and is the largest regional burn center and leading provider of complex tertiary and quaternary care. The system's clinical excellence has consistently placed UCI Health in the top 10 for quality and safety among the nation's leading comprehensive academic health systems. The acquisition also means more patients will have access to advanced therapies in the region's largest and most diverse portfolio of clinical trials, ranging from cancer to neurosciences, digestive diseases, orthopedics and internal medicine specialties. UCI Health and Tenet Healthcare's Pacific Coast Network patients can continue receiving care at their local facilities as they normally would from the care teams they know and trust. The transaction is expected to be completed in spring 2024, subject to customary regulatory approvals, clearances, and closing conditions. "It is a privilege to provide world-class care to Californians and we are excited to welcome the clinicians and co-workers from these Tenet Healthcare sites to UCI Health as partners in improving the health of local communities," Lefteris said. About UCI Health UCI Health is the clinical enterprise of the University of California, Irvine, and the only academic health system in Orange County. Patients can access UCI Health at primary and specialty care offices across Orange County and at its main campus, UCI Medical Center in Orange, Calif. The 459-bed, acute care hospital, listed among America's Best Hospitals by U.S. News & World Report for 23 consecutive years, provides tertiary and quaternary care, ambulatory and specialty medical clinics, behavioral health and rehabilitation services. UCI Medical Center is home to Orange County's only National Cancer Institute-designated comprehensive cancer center, high-risk perinatal/neonatal program and American College of Surgeons-verified Level I adult and Level II pediatric trauma center, gold level 1 geriatric emergency department and regional burn center. About UC Irvine About the University of California, Irvine: Founded in 1965, UCI is a member of the prestigious Association of American Universities and is ranked among the nation's top 10 public universities by U.S. News & World Report. The campus has produced five Nobel laureates and is known for its academic achievement, premier research, innovation and anteater mascot. Led by Chancellor Howard Gillman, UCI has more than 37,000 students and offers 224 degree programs. It's located in one of the world's safest and most economically vibrant communities and is Orange County's second-largest employer, contributing $7 billion annually to the local economy and $8 billion statewide. About Tenet Healthcare Tenet Healthcare Corporation is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates or has ownership interests in more than 480 ambulatory surgery centers and surgical hospitals. We also operate 58 acute care and specialty hospitals, approximately 110 other outpatient facilities, a network of leading employed physicians and a global business center in Manila, Philippines. Our Conifer Health Solutions subsidiary provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers, and other clients. Across the Tenet enterprise, we are united by our mission to deliver quality, compassionate care in the communities we serve.

Read More

Spotlight

Tebra

Tebra

The world of medicine is forever evolving, with new demands and challenges around every corner. We're always looking ahead to bring tomorrow's solutions to today's providers. Some might call it foresight or innovation. We call it Tebra....

Events

Resources